Renal function tests urinalysis

Nursing Implications Monitor CBC, urinalysis, renal function tests Periodically evaluate renal and hematologic systems during prolonged therapy do not inject into gluteal muscle in children less than 2 years of age... 

Laboratory tests for identifying disorders that may cause or worsen HF include compete blood count serum electrolytes (including calcium and magnesium) renal, hepatic, and thyroid function tests urinalysis lipid... 

Blood counfs, renal funcfion fesfs, liver function tests, urinalysis periodically... 

Baseline electrolytes, renal function tests, and urinalysis baseline and at least BUN, creatinine, potassium within 2 weeks after initiation of therapy (increased levels may indicate acute renal failure)... 

Elecfrolyfe levels (especially pofassium), infake and output, renal function test results, and urinalysis results... 

Baseline CBC with differential and liver function tests, then every second week during the first 3 months of therapy, monthly during the second 3 months of therapy, then every 3 months thereafter urinalysis and renal function tests periodically... 

Before tlie initial administration of tlie drug, it is important to assess tlie patient s general appearance and take and record the vital signs. The nurse obtains information regarding tlie symptoms experienced by tlie patient and the lengtli of time these symptoms have been present. Depending on tlie tyiie and location of tlie infection or disease tlie nurse reviews the results of tests, such as a urine culture, urinalysis, complete blood count, intravenous pyelogram, renal function tests, and examination of tlie stool. 

Additional culture and sensitivity tests may be performed during therapy because microorganisms causing the infection may become resistant to penicillin, or a superinfection may have occurred. A urinalysis, complete blood count, and renal and hepatic function tests also may be performed at intervals during therapy. 

It also is important to take and record vital signs before the first dose of die antibiotic is given. The primary health care provider may order culture and sensitivity tests, and tiiese should also be performed before die first dose of die drug is given. Odier laboratory tests such as renal and hepatic function tests, complete blood count, and urinalysis may also be ordered by the primary health care provider. 

Monitoring When indicated, monitor drug toxicity or efficacy through urinalysis. In rheumatoid arthritis patients, discontinue the drug if unexplained gross hematuria or persistent microscopic hematuria develops. Perform liver function tests and an annual x-ray for renal stones. 

CBC, BUN, creatinine (i.e., renal function), urinalysis, thyroid function tests EKG Serum lithium level (drawn 12 hours after dose) every 1-2 weeks until stable every 1—2 months during continuation phase Repeat thyroid function testast and urinalysis every 3-6 months... 

Laboratory investigation of patients with suspected NSIP remains nonspecific yet experts recommend a complete blood count with differential, basic chemistries including assessment of renal function, liver fimction tests, antinuclear antibodies, rheumatoid factor, and a urinalysis (43). 

Early kidney disease is difficult to detect. The urinalysis is normal in early lead nephropathy and the blood urea nitrogen and serum creatinine increase only when two-thirds of kidney function is lost. Measurement of creatinine clearance can often detect earlier disease as can other methods of measurement of glomerular filtration rate. An abnormal Ca-EDTA mobilization test has been used to differentiate between lead-induced and other nephropathies, but this procedure is not widely accepted. A form of Fanconi syndrome with aminoaciduria, glycosuria, and hyperphosphaturia indicating severe injury to the proximal renal tubules is occasionally seen in children. 

---